• PCI-32765 (Ibrutinib): BTK Inhibition in Precision Oncology

  2026-05-25

  Explore how PCI-32765 (Ibrutinib), a potent and selective BTK inhibitor, is redefining translational research in B-cell signaling, with new frontiers emerging in ATRX-deficient glioma models. This thought-leadership article integrates mechanistic insight, validated protocols, and strategic guidance to empower researchers at the intersection of hematologic malignancy, autoimmune modeling, and next-generation precision oncology.

• A23187, Free Acid: Advanced Assay Precision in Drug Response

  2026-05-25

  Explore how A23187, free acid, a leading calcium ionophore, redefines assay precision and viability analysis in in vitro drug response systems. This article reveals strategic innovations, protocol guidance, and scientific context that go beyond standard mechanistic reviews.

• Carfilzomib Enhances Iodine-125-Induced Cell Death in ESCC

  2026-05-24

  This study demonstrates that Carfilzomib (PR-171) significantly sensitizes esophageal squamous cell carcinoma (ESCC) cells to Iodine-125 seed radiation by aggravating endoplasmic reticulum stress, promoting apoptosis, paraptosis, and ferroptosis. These findings highlight a novel multi-modal mechanism for overcoming radioresistance and improving therapeutic strategies for advanced ESCC.

• HDAC Inhibition Enhances Oncolytic Virus Therapy in Meningio

  2026-05-23

  Kawamura et al. demonstrate that histone deacetylase inhibitors (HDACi), including Trichostatin A (TSA), significantly boost the efficacy of oncolytic herpes simplex virus (oHSV) in treating malignant meningioma. Their work uncovers mechanistic synergy, offering a promising combination strategy for an aggressive tumor type with limited current options.

• Laminin (925-933) Peptide for Cell Adhesion and Migration As

  2026-05-22

  Laminin (925-933) empowers researchers with a highly defined extracellular matrix peptide for reliable cell adhesion, migration, and chemotaxis assays. Its precise receptor targeting and quantitative solubility unlock advanced experimental control across cancer, developmental, and stem cell workflows.

• RapaLink-1 and the Next Era of mTOR-Targeted Translational R

  2026-05-22

  Explore how RapaLink-1, a third-generation mTOR inhibitor, is redefining research strategies for overcoming resistance in cancer and enabling scalable induction of embryonic dormancy. This article offers mechanistic insights, strategic guidance, and actionable parameters for translational researchers aiming to bridge oncology and developmental biology.

• LY364947: TGF-β Type I Receptor Kinase Inhibitor for EMT Con

  2026-05-21

  LY364947 empowers researchers with precise and reproducible inhibition of the TGF-β signaling pathway, enabling robust modeling of EMT, fibrosis, and retinal degeneration. Its optimized solubility profile and selectivity distinguish it for both in vitro and in vivo applications where pathway-specific modulation is critical.

• Applied Workflows with Atrial Natriuretic Peptide in Cardiov

  2026-05-21

  Leverage Atrial Natriuretic Peptide (ANP) in rat models for precise, reproducible studies on blood pressure regulation and natriuresis. Discover how APExBIO’s high-purity ANP unlocks advanced cardiovascular workflows, with actionable troubleshooting and protocol tips for maximized assay sensitivity.

• Targeting PCNA-POLD1 Axis Prevents Pathologic Cardiac Hypert

  2026-05-20

  Pal et al. elucidate a mechanistic link between DNA synthesis pathways and pathologic myocardial hypertrophy, demonstrating that p21-mediated disruption of the PCNA-POLD1 interaction suppresses cardiomyocyte endoreplication and adverse cardiac remodeling. These findings identify the DNA synthesis machinery as a promising therapeutic target for cardiac hypertrophy.

• Homer1a Modulation of Caspase-6 Relieves Inflammatory Pain i

  2026-05-20

  This preclinical study demonstrates that Homer1a suppresses the caspase-6/TNF-alpha signaling axis to alleviate inflammatory pain in the spinal dorsal horn. The findings clarify a mechanistic link between synaptic regulation and neuroimmune signaling, highlighting caspase-6 inhibition as a promising strategy for pain research.

• Reelin-SFK Signaling is Essential for Ketamine’s Antidepress

  2026-05-19

  This study demonstrates that synaptic Reelin signaling, particularly through Apoer2 and Src family kinases (SFKs), is a critical permissive factor for ketamine-induced synaptic plasticity and behavioral changes in the hippocampus. Disruption of this pathway may underlie nonresponsiveness to ketamine in treatment-resistant depression, highlighting a mechanistic link with potential translational implications.

• RSV NS3 Modulates Host Signaling to Balance Pathogenicity

  2026-05-19

  Zhuang et al. (2025) reveal that Rice stripe virus NS3 protein finely adjusts viral pathogenicity and transmission by hijacking host kinase signaling pathways through stage-specific phosphorylation. This work uncovers a co-survival strategy in virus-vector-plant interactions, providing new mechanistic insights for translational research on host-pathogen dynamics.

• PP 2 (AG 1879): Precision Src Kinase Inhibition in Cell Mode

  2026-05-18

  PP 2 (AG 1879) delivers nanomolar-selective inhibition of Src family kinases, enabling researchers to dissect cancer and immune cell signaling with confidence. This guide builds on recent breakthroughs in cytoskeletal signaling, providing actionable workflows, advanced troubleshooting, and direct links to robust experimental evidence.

• Simvastatin (Zocor): Deep Phenotypic Profiling in Cancer and

  2026-05-18

  Explore the multidimensional use of Simvastatin (Zocor) as a cholesterol synthesis inhibitor and apoptosis inducer in liver cancer research. This article uniquely integrates machine learning-based phenotypic profiling, providing actionable insights for advanced assay design.

• Annexin V-FITC/PI Apoptosis Assay Kit: Precision in Hepatic

  2026-05-17

  Explore how the Annexin V-FITC/PI Apoptosis Assay Kit empowers advanced apoptosis detection in liver ischemia-reperfusion injury models. This article uniquely bridges mechanistic insights from recent human peptidomics research with practical assay guidance for translational hepatology.

16429 records 1/1096 page Next 12345 下5页 Last page